In the last 12 months, insiders at CURIS INC ($CRIS) filed 65 transactions with the SEC: 1 open-market purchases totaling $5,487 and 0 sales totaling $0. Net insider sentiment: net buying.
CURIS INC operates in the Biological products, (no disgnostic substances) industry (Life sciences sector).
Most Active Insiders
- KAITIN KENNETH I (Director) — 5 transactions totaling $5,505
- Zung Jonathan B. (CDO) — 10 transactions totaling $19
- Dentzer James E (President & CEO) — 10 transactions totaling $18
- Duvall Diantha (CFO) — 10 transactions totaling $18
- Rubin Marc (Director) — 10 transactions totaling $18
View all SEC Filings for CURIS INC (CRIS).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2026 | KAITIN KENNETH I | Director | P | Common Stock | 10000 | $0.55 | 11,407.0000 | 15,680,178 | 710.73% | 0.06% |
| March 20, 2026 | Rubin Marc | Director | C | Series B Convertible Preferred Stock | 20 | $0.00 | 0.0000 | 15,680,178 | 100.00% | 0.00% |
| March 20, 2026 | Rubin Marc | Director | C | Common Stock | 26667 | $0.00 | 28,108.0000 | 15,680,178 | 1850.59% | 0.17% |
| March 20, 2026 | Dentzer James E | President & CEO | C | Series B Convertible Preferred Stock | 100 | $0.00 | 0.0000 | 15,680,178 | 100.00% | 0.00% |
| March 20, 2026 | Dentzer James E | President & CEO | C | Common Stock | 133333 | $0.00 | 148,730.0000 | 15,680,178 | 865.97% | 0.85% |
| March 20, 2026 | Duvall Diantha | CFO | C | Series B Convertible Preferred Stock | 50 | $0.00 | 0.0000 | 15,680,178 | 100.00% | 0.00% |
| March 20, 2026 | Duvall Diantha | CFO | C | Common Stock | 66666 | $0.00 | 77,707.0000 | 15,680,178 | 603.80% | 0.43% |
| March 20, 2026 | Hamdy Ahmed MD | CMO | C | Series B Convertible Preferred Stock | 50 | $0.00 | 0.0000 | 15,680,178 | 100.00% | 0.00% |
| March 20, 2026 | Hamdy Ahmed MD | CMO | C | Common Stock | 66667 | $0.00 | 66,667.0000 | 15,680,178 | 9999.99% | 0.43% |
| March 20, 2026 | Zung Jonathan B. | CDO | C | Common Stock | 66667 | $0.00 | 66,667.0000 | 15,680,178 | 9999.99% | 0.43% |
| March 20, 2026 | Zung Jonathan B. | CDO | C | Series B Convertible Preferred Stock | 50 | $0.00 | 0.0000 | 15,680,178 | 100.00% | 0.00% |
| March 17, 2026 | Dentzer James E | President & CEO | A | Series C Warrant (right to buy) | 133333 | $0.00 | 133,333.0000 | 15,680,178 | 9999.99% | 0.85% |
| March 17, 2026 | Zung Jonathan B. | CDO | A | Series B Convertible Preferred Stock | 50 | $0.00 | 50.0000 | 15,680,178 | 9999.99% | 0.00% |
| March 17, 2026 | Zung Jonathan B. | CDO | A | Series A Warrant (right to buy) | 66667 | $0.00 | 66,667.0000 | 15,680,178 | 9999.99% | 0.43% |
| March 17, 2026 | Zung Jonathan B. | CDO | A | Series B Warrant (right to buy) | 66667 | $0.00 | 66,667.0000 | 15,680,178 | 9999.99% | 0.43% |
| March 17, 2026 | Zung Jonathan B. | CDO | A | Series C Warrant (right to buy) | 66667 | $0.00 | 66,667.0000 | 15,680,178 | 9999.99% | 0.43% |
| March 17, 2026 | Hamdy Ahmed MD | CMO | A | Series B Convertible Preferred Stock | 50 | $0.00 | 50.0000 | 15,680,178 | 9999.99% | 0.00% |
| March 17, 2026 | Hamdy Ahmed MD | CMO | A | Series A Warrant (right to buy) | 66667 | $0.00 | 66,667.0000 | 15,680,178 | 9999.99% | 0.43% |
| March 17, 2026 | Hamdy Ahmed MD | CMO | A | Series B Warrant (right to buy) | 66667 | $0.00 | 66,667.0000 | 15,680,178 | 9999.99% | 0.43% |
| March 17, 2026 | Hamdy Ahmed MD | CMO | A | Series C Warrant (right to buy) | 66667 | $0.00 | 66,667.0000 | 15,680,178 | 9999.99% | 0.43% |
| March 17, 2026 | Duvall Diantha | CFO | A | Series B Convertible Preferred Stock | 50 | $0.00 | 50.0000 | 15,680,178 | 9999.99% | 0.00% |
| March 17, 2026 | Duvall Diantha | CFO | A | Series A Warrant (right to buy) | 66666 | $0.00 | 66,666.0000 | 15,680,178 | 9999.99% | 0.43% |
| March 17, 2026 | Duvall Diantha | CFO | A | Series B Warrant (right to buy) | 66666 | $0.00 | 66,666.0000 | 15,680,178 | 9999.99% | 0.43% |
| March 17, 2026 | Duvall Diantha | CFO | A | Series C Warrant (right to buy) | 66666 | $0.00 | 66,666.0000 | 15,680,178 | 9999.99% | 0.43% |
| March 17, 2026 | Dentzer James E | President & CEO | A | Series B Convertible Preferred Stock | 100 | $0.00 | 100.0000 | 15,680,178 | 9999.99% | 0.00% |
| March 17, 2026 | Dentzer James E | President & CEO | A | Series A Warrant (right to buy) | 133333 | $0.00 | 133,333.0000 | 15,680,178 | 9999.99% | 0.85% |
| March 17, 2026 | Dentzer James E | President & CEO | A | Series B Warrant (right to buy) | 133333 | $0.00 | 133,333.0000 | 15,680,178 | 9999.99% | 0.85% |
| March 17, 2026 | Rubin Marc | Director | A | Series B Convertible Preferred Stock | 20 | $0.00 | 20.0000 | 15,680,178 | 9999.99% | 0.00% |
| March 17, 2026 | Rubin Marc | Director | A | Series A Warrant (right to buy) | 26667 | $0.00 | 26,667.0000 | 15,680,178 | 9999.99% | 0.17% |
| March 17, 2026 | Rubin Marc | Director | A | Series B Warrant (right to buy) | 26667 | $0.00 | 26,667.0000 | 15,680,178 | 9999.99% | 0.17% |
| March 17, 2026 | Rubin Marc | Director | A | Series C Warrant (right to buy) | 26667 | $0.00 | 26,667.0000 | 15,680,178 | 9999.99% | 0.17% |
| May 20, 2025 | Duvall Diantha | CFO | A | Employee stock option (right to buy) | 135000 | $3.13 | 135,000.0000 | 6,306,284 | 9999.99% | 2.14% |
| May 20, 2025 | Rubin Marc | Director | A | Non Qualified Stock Option | 14400 | $3.13 | 14,400.0000 | 6,306,284 | 9999.99% | 0.23% |
| May 20, 2025 | GREENACRE MARTYN D | Director | A | Non Qualified Stock Option | 14400 | $3.13 | 14,400.0000 | 6,306,284 | 9999.99% | 0.23% |
| May 20, 2025 | Dentzer James E | President & CEO | A | Employee stock option (right to buy) | 360000 | $3.13 | 360,000.0000 | 6,306,284 | 9999.99% | 5.71% |
| May 20, 2025 | Hohneker John | Director | A | Non Qualified Stock Option | 14400 | $3.13 | 14,400.0000 | 6,306,284 | 9999.99% | 0.23% |
| May 20, 2025 | KAITIN KENNETH I | Director | A | Non Qualified Stock Option | 14400 | $3.13 | 14,400.0000 | 6,306,284 | 9999.99% | 0.23% |
| May 20, 2025 | Zung Jonathan B. | CDO | A | Employee stock option (right to buy) | 135000 | $3.13 | 135,000.0000 | 6,306,284 | 9999.99% | 2.14% |
| May 20, 2025 | Borgman Anne Elizabeth | Director | A | Non Qualified Stock Option | 14400 | $3.13 | 14,400.0000 | 6,306,284 | 9999.99% | 0.23% |
| May 1, 2025 | Hamdy Ahmed MD | CMO | A | Employee stock option (right to buy) | 200000 | $2.48 | 200,000.0000 | 6,306,284 | 9999.99% | 3.17% |
| Jan. 28, 2025 | Hohneker John | Director | A | Non Qualified Stock Option | 1600 | $3.13 | 1,600.0000 | 6,306,284 | 9999.99% | 0.03% |
| Jan. 28, 2025 | Dentzer James E | President & CEO | A | Employee stock option (right to buy) | 40000 | $3.13 | 40,000.0000 | 6,306,284 | 9999.99% | 0.63% |
| Jan. 28, 2025 | GREENACRE MARTYN D | Director | A | Non Qualified Stock Option | 1600 | $3.13 | 1,600.0000 | 6,306,284 | 9999.99% | 0.03% |
| Jan. 28, 2025 | Duvall Diantha | CFO | A | Employee stock option (right to buy) | 15000 | $3.13 | 15,000.0000 | 6,306,284 | 9999.99% | 0.24% |
| Jan. 28, 2025 | Zung Jonathan B. | CDO | A | Employee stock option (right to buy) | 15000 | $3.13 | 15,000.0000 | 6,306,284 | 9999.99% | 0.24% |
| Jan. 28, 2025 | KAITIN KENNETH I | Director | A | Non Qualified Stock Option | 1600 | $3.13 | 1,600.0000 | 6,306,284 | 9999.99% | 0.03% |
| Jan. 28, 2025 | Borgman Anne Elizabeth | Director | A | Non Qualified Stock Option | 1600 | $3.13 | 1,600.0000 | 6,306,284 | 9999.99% | 0.03% |
| Jan. 28, 2025 | Rubin Marc | Director | A | Non Qualified Stock Option | 1600 | $3.13 | 1,600.0000 | 6,306,284 | 9999.99% | 0.03% |
| May 21, 2024 | Borgman Anne Elizabeth | Director | A | Non Qualified Stock Option | 4250 | $11.62 | 4,250.0000 | 5,293,294 | 9999.99% | 0.08% |
| May 21, 2024 | GREENACRE MARTYN D | Director | A | Non Qualified Stock Option | 4250 | $11.62 | 4,250.0000 | 5,293,294 | 9999.99% | 0.08% |
| May 21, 2024 | Hohneker John | Director | A | Non Qualified Stock Option | 4250 | $11.62 | 4,250.0000 | 5,293,294 | 9999.99% | 0.08% |
| May 21, 2024 | Duvall Diantha | CFO | A | Employee stock option (right to buy) | 39000 | $11.62 | 39,000.0000 | 5,293,294 | 9999.99% | 0.74% |
| May 21, 2024 | Dentzer James E | President & CEO | A | Employee stock option (right to buy) | 100000 | $11.62 | 100,000.0000 | 5,293,294 | 9999.99% | 1.89% |
| May 21, 2024 | Zung Jonathan B. | CDO | A | Employee stock option (right to buy) | 40700 | $11.62 | 40,700.0000 | 5,293,294 | 9999.99% | 0.77% |
| May 21, 2024 | KAITIN KENNETH I | Director | A | Non Qualified Stock Option | 4250 | $11.62 | 4,250.0000 | 5,293,294 | 9999.99% | 0.08% |
| May 21, 2024 | Rubin Marc | Director | A | Non Qualified Stock Option | 4250 | $11.62 | 4,250.0000 | 5,293,294 | 9999.99% | 0.08% |
| May 1, 2023 | Zung Jonathan B. | CDO | A | Employee stock option (right to buy) | 500000 | $0.83 | 500,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 23, 2023 | GREENACRE MARTYN D | Director | A | Non Qualified Stock Option | 85000 | $0.00 | 85,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 20, 2023 | Duvall Diantha | CFO | A | Employee stock option (right to buy) | 500000 | $0.00 | 500,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 20, 2023 | Martell Robert | Head of Research & Development | A | Employee stock option (right to buy) | 350000 | $0.00 | 350,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 20, 2023 | Dentzer James E | President & CEO | A | Employee stock option (right to buy) | 1000000 | $0.00 | 1,000,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 23, 2023 | KAITIN KENNETH I | Director | A | Non Qualified Stock Option | 85000 | $0.00 | 85,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 23, 2023 | Hohneker John | Director | A | Non Qualified Stock Option | 85000 | $0.00 | 85,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 23, 2023 | Rubin Marc | Director | A | Non Qualified Stock Option | 85000 | $0.00 | 85,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 23, 2023 | Borgman Anne Elizabeth | Director | A | Non Qualified Stock Option | 85000 | $0.00 | 85,000.0000 | 0 | 9999.99% | 0.00% |